The Molecular Analysis for Precision Oncology Congress is a leading global meeting dedicated to understanding molecular developments that can help in making cancer treatment more personalised.

The Congress is the place to follow high profile researchers, from state of the art laboratories, presenting new data as well as multidisciplinary teams sharing their achievements.

MAP 2021, positioned at the interface between basic science and clinical application, will highlight emerging breakthroughs in molecular characterisation and clonal evolution of malignancies, in the complex regulation of the microenvironment and host immune response and will showcase the advances in new therapeutic targets, such as epigenetic regulators, myeloid cells and pivotal oncogenes.

This is a must-attend meeting for every cancer researcher, basic, translational or clinical, willing to investigate the cancer complexity and understand more about the mechanisms behind it.

The MAP Congress is the result of a solid partnership among Cancer Research UK (CRUK), the European Society for Medical Oncology (ESMO) and Unicancer, all committed to offering the best care to people with cancer worldwide, through oncology education and research.